Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "market"

3695 News Found

MTPA announces long-term findings from post-marketing safety study of Radicava
News | June 30, 2022

MTPA announces long-term findings from post-marketing safety study of Radicava

Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone


NADMED brings first CE-marked NAD+ analysis kit to the market
Medical Device | June 30, 2022

NADMED brings first CE-marked NAD+ analysis kit to the market

NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites


AeroSafe Global appointment Jessica Cao as Sr VP (Marketing)
People | June 11, 2022

AeroSafe Global appointment Jessica Cao as Sr VP (Marketing)

Company hires life science veteran Jessica Cao to join management team


Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market
News | June 07, 2022

Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market

The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price


Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
News | June 04, 2022

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030


Moderna to become marketing authorization holder in Japan for Spikevax
News | June 01, 2022

Moderna to become marketing authorization holder in Japan for Spikevax

Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period


MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
Biotech | May 29, 2022

MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData

RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised


Bempedoic acid market in India will get crowded soon:  GlobalData
News | May 27, 2022

Bempedoic acid market in India will get crowded soon: GlobalData

Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe


Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market
News | May 25, 2022

Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market

The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA


Borrena approval strengthens Pfizer position in China NSCLC market: GlobalData
News | May 25, 2022

Borrena approval strengthens Pfizer position in China NSCLC market: GlobalData

According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029